MEGAN WEAVER: Open Payments
NPI 1457633786 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,251 in 137 payments from 46 companies in 2025. Trend: 2023 $3,059 · 2024 $2,977 · 2025 $3,251
Food & beverage: $3,156Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $366 |
| PFIZER INC. | 14 | $272 |
| Novartis Pharmaceuticals Corporation | 12 | $260 |
| Merck Sharp & Dohme LLC | 9 | $226 |
| Daiichi Sankyo Inc. | 7 | $182 |
| Gilead Sciences, Inc. | 5 | $124 |
| Syndax Pharmaceuticals, Inc. | 2 | $110 |
| Incyte Corporation | 4 | $99 |
| SEAGEN INC. | 1 | $95 |
| Janssen Biotech, Inc. | 4 | $89 |
Products named: KEYTRUDA, Enhertu, KISQALI, ELREXFIO, IMFINZI, Trodelvy, Epkinly, Padcev.
Industry payments across IN — which companies pay providers there.
